Used as a chiral ligand in asymmetric catalysis, particularly in enantioselective transformations such as hydrogenation and transfer hydrogenation reactions. Its rigid cyclohexane backbone and pyridyl coordination sites enable strong metal binding, commonly with ruthenium, rhodium, or iridium, to form highly selective catalysts. These complexes are effective in producing enantiomerically enriched amines, alcohols, and other fine chemicals important in pharmaceutical synthesis. The ligand’s stereochemistry enhances facial selectivity in substrate approach, leading to high enantiomeric excess. It is also employed in C–C bond formation reactions and has shown utility in catalytic asymmetric synthesis of biologically active molecules.